Related Experiment Video
Updated: Nov 6, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study
Astrid M Suchy-Dicey1,2, Ying Zhang3, Sterling McPherson1
1Elson S Floyd College of Medicine, Washington State University, Spokane, Washington.
Insights
Rapid kidney function decline in American Indians is linked to higher mortality and cardiovascular disease risk, even without diagnosed chronic kidney disease. Evaluating kidney function change over time is crucial for long-term health.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Epidemiology
Background:
- Rapid kidney function decline is a significant predictor of mortality and cardiovascular disease (CVD), independent of chronic kidney disease (CKD).
- American Indians (AI) experience a disproportionately high burden of kidney disease, CVD, and stroke.
- This study investigates extreme loss of glomerular function in AI and its association with clinical outcomes.
Purpose of the Study:
- To examine the association between rapid decline in estimated glomerular filtration rate (eGFR) and clinical outcomes in American Indians.
- To determine if extreme eGFR loss predicts mortality and cardiovascular events in this population.
- To highlight the importance of monitoring kidney function changes over time.
Main Methods:
- Utilized data from the Strong Heart Study, a longitudinal cohort of adult AI participants (1989-1999).
- Calculated intraindividual regressions of eGFR to estimate linear changes in kidney function.
- Monitored mortality and cardiovascular events through physician-adjudicated surveillance until 2017.
Main Results:
- Mean eGFR decline was 6.8 mL/min over 10 years; the top 1% lost ~5.7 mL/min/year.
- Extreme eGFR loss (>20 mL/min) was independently associated with increased mortality (HR 3.5) and composite CVD events (HR 1.4).
- Diabetes and hypertension were more prevalent in participants with extreme eGFR loss.
Conclusions:
- This is the first study to examine eGFR decline in association with mortality and CVD in American Indians.
- Clinical evaluation should consider eGFR change over time, not just baseline eGFR or CKD status.
- Findings suggest that aspects of renal function not captured by CKD diagnosis may significantly impact long-term renal and vascular health.
Background:
Rapid kidney decline is associated with mortality and cardiovascular disease, even in the absence of chronic kidney disease. American Indians (AI) have particularly high burden of kidney disease, cardiovascular disease, and stroke. This study aims to examine extreme loss in glomerular function in this population in association with clinical outcomes.
Methods:
The Strong Heart Study, a large longitudinal cohort of adult AI participants, collected plasma creatinine at 3 examination visits between 1989-1999. Intraindividual regressions of estimated glomerular filtration rate (eGFR) provided linear estimates of change in kidney function over this time period. Surveillance with physician adjudication identified mortality and cardiovascular events between visit 3 through 2017.
Results:
Mean change in eGFR was loss 6.8 mL/min over the ten year baseline (range: -66.0 to +28.9 mL/min). The top 1 percentile lost approximately 5.7 mL/min/year. Participants with extreme eGFR loss were more likely to have diabetes (95% vs 71%), hypertension (49% vs 33%), or longer smoking history, among smokers (19 pack years vs 17 pack years). CKD (eGFR<60 mL/min) was associated only with mortality, independent of slope: HR 1.1 (95% CI 1.0-1.3). However, extreme loss in eGFR (>20 mL/min over baseline period) was associated with mortality, independent of baseline eGFR: HR 3.5 (95% CI 2.7-4.4), and also independently associated with composite CVD events and CHF: HR 1.4 and 1.7 (95% CI 1.1-1.9 and 1.2-2.6), respectively.
Conclusion:
This is the first examination of decline in eGFR in association with mortality and CVD among AIs. The implications of these findings are broad: clinical evaluation may benefit from evaluating change in eGFR over time in addition to dichotomous eGFR. Also, these findings suggest there may be aspects of renal function that are not well-marked by clinical CKD, but which may have particular relevance to long-term renal and vascular health.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics

